Mar­ket­ingRx roundup: Lund­beck’s Vyep­ti joins mi­graine TV ad bat­tle; Pfiz­er de­buts Covid treat­ment TV ad

Lund­beck de­buted its first TV ad cam­paign for in­fused mi­graine med­i­cine Vyep­ti – in­to an al­ready crowd­ed field. How­ev­er, Vyep­ti is high­light­ing its unique IV …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.